首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1569490

免疫診斷市場規模、佔有率和成長分析：按產品、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Immunodiagnostics Market Size, Share, Growth Analysis, By Product (Instruments, Reagents & Consumables), By Application (Cardiac Markers, Infectious Diseases), By End user (Clinical Laboratories, Hospitals), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球免疫診斷市場規模為232億美元，從2023年的241.7億美元增加至2031年的336億美元，複合年成長率預計為4.20%。

由於幾個關鍵因素，全球免疫診斷市場預計將出現強勁成長。免疫診斷學採用基於免疫的檢測方法來診斷和監測多種疾病，而感染疾病、自體免疫疾病和癌症的日益流行極大地推動了對準確、高效的診斷解決方案的需求。免疫測量技術的進步，包括酵素結合免疫吸附檢測法（ELISA）、化學冷光免疫檢測（CLIA）和快速診斷測試，顯著提高了靈敏度和特異性，有助於市場擴張。此外，人們對早期疾病檢測重要性的認知不斷提高以及個人化醫療的日益普及，並持續刺激對免疫診斷工具的需求。因此，美國免疫診斷市場預計明年將維持持續的複合年成長率。這一趨勢凸顯了人們越來越依賴創新診斷技術來有效應對健康挑戰並改善患者的治療結果。總體而言，技術創新和意識增強的結合使免疫診斷領域在醫療保健領域取得了實質進展。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Abbott（US）
Roche Diagnostics（Switzerland）
DiaSorin（Italy）
Danaher Corporation（US）
QIAGEN（Netherlands）
bioMerieux（France）
Thermo Fisher Scientific（US）
Quest Diagnostics（US）
Siemens Healthineers AG（Germany）
Bio-Rad Laboratories, Inc.（US）
Sysmex Corporation（Japan）
PerkinElmer, Inc.（US）
Agilent Technologies, Inc.（US）
Mindray Medical International Limited（China）
Grifols, SA（Spain）
Becton, Dickinson and Company（BD）（US）
Abcam plc（UK）
Merck KGaA（Germany）
Enzo Biochem, Inc.（US）
Bio-Techne Corporation（US）
Meso Scale Diagnostics, LLC.（US）
GenScript Biotech Corporation（China）
Myriad Genetics, Inc.（US）

簡介目錄

Product Code: SQMIG35A2401

Global Immunodiagnostics Market size was valued at USD 23.2 billion in 2022 and is poised to grow from USD 24.17 billion in 2023 to USD 33.6 billion by 2031, growing at a CAGR of 4.20% during the forecast period (2024-2031).

The global immunodiagnostics market is poised for robust growth, driven by multiple key factors. Immunodiagnostics involves employing immune-based assays to diagnose and monitor a wide array of diseases, and the increasing incidence of infectious diseases, autoimmune disorders, and cancer is significantly boosting the demand for precise and efficient diagnostic solutions. Technological advancements in immunoassay methodologies, including enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), and rapid diagnostic tests, have notably enhanced sensitivity and specificity, thereby contributing to market expansion. Furthermore, a growing awareness regarding the importance of early disease detection, coupled with the rising popularity of personalized medicine, continues to stimulate demand for immunodiagnostic tools. As a result, the U.S. immunodiagnostics market is anticipated to maintain a sustainable compound annual growth rate (CAGR) in the upcoming forecast year. This trend highlights the increasing reliance on innovative diagnostic methods to effectively address health challenges and improve patient outcomes. Overall, the convergence of technological innovations and heightened awareness positions the immunodiagnostics sector for substantial progression in the healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the global immunodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global immunodiagnostics Market Segmental Analysis

Global Immunodiagnostics Market is segmented by Product, Application, End user, and region. Based on Product, the market is segmented into Instruments, and Reagents & Consumables. Based on Application, the market is segmented into Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases, and Others. Based on End user, the market is segmented into Clinical Laboratories, Hospitals, Physician's Offices, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global immunodiagnostics Market

The increasing emphasis on early disease detection is driving the global immunodiagnostics market, as healthcare providers recognize that timely intervention can significantly enhance treatment outcomes and lower overall healthcare expenses. Immunodiagnostics play a pivotal role by enabling the identification of specific biomarkers and molecular targets, which in turn supports early diagnosis and the development of personalized treatment strategies tailored to individual patient profiles. This shift towards precision medicine not only fosters more effective clinical decisions but also promotes patient-centered care, thereby propelling demand for immunodiagnostic solutions across various healthcare settings and ultimately reinforcing market growth.

Restraints in the global immunodiagnostics Market

One of the primary market restraints for the global immunodiagnostics market is the high cost associated with the acquisition and maintenance of diagnostic equipment and reagents. These financial burdens can hinder the adoption of immunodiagnostic tests, particularly in resource-limited settings where healthcare budgets are constrained. As hospitals and clinics in developing regions grapple with limited funding and competing healthcare priorities, the significant investment required for immunodiagnostic technologies may deter facilities from implementing these advanced diagnostic solutions. Consequently, this pricing challenge can impede the overall growth and accessibility of immunodiagnostics, ultimately affecting patient care and outcomes in underserved populations.

Market Trends of the global immunodiagnostics Market

In recent years, the global immunodiagnostics market has witnessed a significant trend towards the integration of digital health solutions driven by technological advancements and an increased demand for efficient healthcare delivery. This shift encompasses the adoption of online platforms for testing, mobile applications for result tracking, and telehealth services that facilitate remote consultations and monitoring. As patients and providers leverage wearables and remote diagnostic tools, the immunodiagnostics sector is increasingly characterized by real-time data sharing, streamlined workflows, and enhanced patient engagement. This trend is expected to bolster market growth, reflecting a larger movement towards personalized and accessible healthcare solutions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Immunodiagnostics Market by Product

Market Overview
Instruments
Reagents & Consumables

Immunodiagnostics Market by Application

Market Overview
Oncology & Endocrinology
Hepatitis & Retrovirus
Cardiac Markers
Infectious Diseases
Others

Immunodiagnostics Market by End user

Market Overview
Clinical Laboratories
Hospitals
Physician's Offices
Online Pharmacies

Immunodiagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical International Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meso Scale Diagnostics, LLC. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments